Compare Kenvue Inc. Common Stock (KVUE) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kenvue Inc. Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Kenvue Inc. Common Stock trades at $17.71 (market cap $34.06B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.78 (market cap $2.27B). The key difference: Kenvue Inc. Common Stock is far larger — about 15× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| KVUE | SLS | |
|---|---|---|
Market Cap | $34.06B | $2.27B |
Volume | 23,267,228 | 4,179,659 |
Sector | Consumer Staples | Health |
52-Week High | $19.83 | $15.46 |
52-Week Low | $14.11 | $1.39 |
Enterprise Value | $41.56B | $2.14B |
Dividend Yield | 4.74% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
